Moussa, Magdy
Leila, Mahmoud
Elashri, Mohammed Fotouh
Hashem, Ahmed Osama
Funding for this research was provided by:
Tanta University
Article History
Received: 7 January 2025
Accepted: 17 May 2025
First Online: 5 June 2025
Declarations
:
: The ethical committee of the Ophthalmology Department, Faculty of Medicine, Kafr El Sheikh University approved the study. The study adhered strictly to the tenets of the Helsinki Declaration of 1975 and the revision of 2013. All patients, either in person or their parents, received a thorough explanation of the ocular imaging procedures and the intravitreal injection of aflibercept, including its off-label use, possible outcomes, and expected complications, and signed an informed consent.
: The informed consent signed by all patients included a statement authorizing the authors to publish patients’ data anonymously without revealing their identities or any personally identifying information.
: The authors declare no competing interests.